Advancing New Treatments For Patients With Diseases That Are Underserved By Today’s Therapies

Learn More

Recent Press Releases

November 10, 2020: miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
October 28, 2020: miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
October 5, 2020: miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)
September 14, 2020: miRagen Announces Leadership Transition and Review of Strategic Alternatives
August 20, 2020: miRagen Announces Results of Meeting With FDA Regarding the Design of Pivotal Trial for Cobomarsen in ATLL